Elan cuts losses by €100m

Ireland-headquartered US pharmaceutical company Elan has cut losses by more than $130m (€101.8m) in 2004 over the previous year.

In an announcement today of its full-year 2004 financial results, Elan said net loss was down from $508.7m (€398.5m) to $375.9m (€294.4m).